What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His main research concerns Prostate cancer, Surgery, Internal medicine, Cancer and Oncology.
Robert Huddart combines subjects such as Radiation therapy, Depression and Anxiety with his study of Prostate cancer.
His work deals with themes such as Hazard ratio and Urology, which intersect with Surgery.
His Cancer research incorporates elements of Single-nucleotide polymorphism, Genome-wide association study, Side effect and Gynecology.
The study incorporates disciplines such as Genotyping and Case-control study in addition to Single-nucleotide polymorphism.
In his research on the topic of Oncology, Prostatectomy is strongly related with Pathology.
His most cited work include:
- Multiple newly identified loci associated with prostate cancer susceptibility. (754 citations)
- Multiple newly identified loci associated with prostate cancer susceptibility. (754 citations)
- Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial (741 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Oncology, Radiation therapy, Surgery and Chemotherapy.
Prostate cancer, Testicular cancer, Cancer and Clinical endpoint are the primary areas of interest in his Internal medicine study.
As a member of one scientific family, Robert Huddart mostly works in the field of Prostate cancer, focusing on Single-nucleotide polymorphism and, on occasion, Genotyping.
His Oncology study combines topics in areas such as Germ cell tumors, Pathology and Germ cell.
His Radiation therapy research includes elements of Bladder cancer, Toxicity, Randomized controlled trial and Nuclear medicine.
His work carried out in the field of Surgery brings together such families of science as Hazard ratio, Clinical trial and Urology.
He most often published in these fields:
- Internal medicine (44.95%)
- Oncology (35.81%)
- Radiation therapy (31.05%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (44.95%)
- Oncology (35.81%)
- Radiation therapy (31.05%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Oncology, Radiation therapy, Radiology and Bladder cancer.
His Oncology study integrates concerns from other disciplines, such as Genome-wide association study, Regimen, Germ cell cancer, Germ cell and Locally advanced.
His Radiation therapy research integrates issues from Clinical endpoint, Magnetic resonance imaging, General surgery, Hazard ratio and Cystectomy.
His studies in Radiology integrate themes in fields like Standard treatment, Seminoma and Prostate cancer.
His Prostate cancer study improves the overall literature in Cancer.
His studies deal with areas such as Biomarker, Concomitant, Randomized controlled trial and Adaptive radiotherapy as well as Bladder cancer.
Between 2018 and 2021, his most popular works were:
- Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma. (279 citations)
- Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial (18 citations)
- Patient-reported Quality of Life Outcomes in Patients Treated for Muscle-invasive Bladder Cancer with Radiotherapy ± Chemotherapy in the BC2001 Phase III Randomised Controlled Trial (17 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
His scientific interests lie mostly in Radiation therapy, Internal medicine, Bladder cancer, Clinical endpoint and Oncology.
The concepts of his Radiation therapy study are interwoven with issues in Magnetic resonance imaging and Quality of life.
Dose fractionation, Cohort study and Absolute risk reduction are among the areas of Internal medicine where the researcher is concentrating his efforts.
His Bladder cancer research incorporates themes from Lower risk, Randomized controlled trial, Rectum and Chemoradiotherapy.
His research integrates issues of Muscle invasive, Locally advanced, Chemotherapy, Prospective cohort study and Germ cell cancer in his study of Oncology.
His study looks at the intersection of Radiology and topics like Cohort with Toxicity, Prostate cancer and Cancer.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
